Christopher Paul Simms - 02 Aug 2022 Form 4 Insider Report for IVERIC bio, Inc.

Signature
/s/ Todd D.C. Anderman, as Attorney-in-Fact for Christopher Simms
Issuer symbol
N/A
Transactions as of
02 Aug 2022
Net transactions value
-$138,060
Form type
4
Filing time
04 Aug 2022, 16:09:58 UTC
Previous filing
20 Dec 2021
Next filing
22 Dec 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ISEE Common Stock Options Exercise $0 +15,000 +212% $0.000000 22,069 02 Aug 2022 Direct F1
transaction ISEE Common Stock Options Exercise $0 +18,750 +85% $0.000000 40,819 02 Aug 2022 Direct F1
transaction ISEE Common Stock Sale $61,358 -5,454 -13% $11.25 35,365 03 Aug 2022 Direct F2, F3
transaction ISEE Common Stock Sale $76,702 -6,818 -19% $11.25 28,547 03 Aug 2022 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ISEE Restricted Stock Units Options Exercise $0 -15,000 -100% $0.000000* 0 02 Aug 2022 Common Stock 15,000 Direct F4, F5
transaction ISEE Restricted Stock Units Options Exercise $0 -18,750 -25% $0.000000 56,250 02 Aug 2022 Common Stock 18,750 Direct F4, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units.
F2 Represents shares automatically sold pursuant to the prespecified terms of the applicable Restricted Stock Unit Agreement to satisfy the Reporting Person's minimum statutory withholding obligations with respect to the income recognized by the Reporting Person upon the vesting of the restricted stock units on August 2, 2022.
F3 The sale price of the Reporting Person's shares represents the weighted average price of all shares sold by a broker in multiple transactions ranging from $11.14 to $11.38 per share on August 3, 2022 on behalf of a group of employees of the Registrant to satisfy the payment of withholding tax liability of such employees.
F4 Each restricted stock unit represents the contingent right to receive one share of common stock of the Registrant upon vesting of the unit.
F5 Subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2019 Inducement Stock Incentive Plan, the award of restricted stock units will vest with respect to 100% of the shares subject to the award on the first anniversary of the grant date.
F6 Subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2019 Inducement Stock Incentive Plan, the award of restricted stock units will vest with respect to 25% of the shares subject to the award on each of the first, second, third and fourth anniversaries of the grant date.